Xueyan Wang
Henan University
6 Papers
13 Citations
Xueyan Wang is an academic researcher from Henan University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
The relative efficacy and safety of targeted agents used in combination with chemotherapy in treating patients with untreated advanced gastric cancer: a network meta-analysis.
TL;DR: Trastuzumab was recommended as the optimal targeted agent combined with chemotherapy for gastric cancer patients and compared with other analyzed treatments, ramucirumab is outstanding in survival outcomes.
PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer
Xueyan Wang,Jing Yu,Xiaowei Liu,Dan Luo,Yanchu Li,Linlin Song,Xian-Zhen Jiang,Xiaomeng Yin,Yan Wang,Li Chai,Ting Luo,Jing Jing,Hubing Shi +12 more
TL;DR: In this paper , a genome-wide CRISPR-Cas9 library screening was conducted to find that inhibition of PSMG2 sensitizes TNBC cells BT549 and MB468 to the MEK inhibitor AZD6244.
16
Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies
TL;DR: Wang et al. as mentioned in this paper discussed the potential pathogenic mechanisms of CIP, including disordered T cell subsets, the increase of autoantibodies, cross-antigens reactivity, and the potential role of other immune cells.
Editorial: Improvement of melanoma immune checkpoint blockade therapy with potential combinatorial regiments
TL;DR: Wang, Liu, Hugo, Si and Shi as mentioned in this paper published an open-access article under the terms of the Creative Commons Attribution License (CC BY), provided the original author(s) and the copyright owners are credited and that the original publication in this journal is cited, in accordance with accepted academic practice.
Facile Synthesis of Fe3O4@Au/PPy-DOX Nanoplatform with Enhanced Glutathione Depletion and Controllable Drug Delivery for Enhanced Cancer Therapeutic Efficacy
Chunxia Qi,Wanni Wang,Peisan Wang,Hanlong Cheng,Xueyan Wang,Baoyou Gong,Anjian Xie,Yuhua Shen +7 more
TL;DR: In vivo and in vitro results identified that the Fe3O4@Au/PPy-DOX nanoplatform had good biocompatibility and magnetic-targeted synergetic CDT/PDT/PTT/chemotherapy antitumor effects, which were much better than those of the corresponding mono/bi/tri-therapies.